UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia

Haematologica (Roma), 2022-12, Vol.107 (12), p.2977

2022

Volltextzugriff (PDF)

Vapor-Phase (p, ρ, T, x) Behavior of the (Hydrogen + Argon) System

Journal of chemical and engineering data, 2020-07, Vol.65 (7), p.3728-3734

2020

Volltextzugriff (PDF)

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma

Journal of cancer research and clinical oncology, 2015-09, Vol.141 (9), p.1689-1695

2015

Volltextzugriff (PDF)

Speeds of Sound in n-Hexane and n-Heptane at Temperatures from (233.33 to 353.21) K and Pressures up to 20 MPa

International journal of thermophysics, 2021-02, Vol.42 (2), Article 18

2021

Volltextzugriff (PDF)

Measurement and Correlation of the (p, ρ, T) Behavior of Liquid Methanol at Temperatures from 283.15 to 423.15 K and Pressures up to 90 MPa

Industrial & engineering chemistry research, 2021-03, Vol.60 (9), p.3745-3757

2021

Volltextzugriff (PDF)

Speeds of Sound in Methanol at Temperatures from 233.33 to 353.21 K at Pressures up to 20 MPa

International journal of thermophysics, 2021-05, Vol.42 (5), Article 65

2021

Volltextzugriff (PDF)

Measurement of the (p, ρ, T) Behavior of Liquid MEA and DEA at Temperatures from (293.15 to 423.15) K and Pressures up to 90 MPa

International journal of thermophysics, 2021, Vol.42 (5), Article 70

2021

Volltextzugriff (PDF)

(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial

Journal of clinical oncology, 2013-01, Vol.31 (3), p.308

2013

Volltextzugriff (PDF)

Speeds of Sound in n‑Pentane at Temperatures from 233.50 to 473.15 K at Pressures up to 390 MPa

Journal of chemical and engineering data, 2020-07, Vol.65 (7), p.3679-3689

2020

Volltextzugriff (PDF)

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

Annals of hematology, 2022-04, Vol.101 (4), p.781-788

2022

Volltextzugriff (PDF)

Controlled non‐randomised before–after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients—The Easy Vaccination in Oncology (EVO) strategy

European journal of cancer care, 2022-11, Vol.31 (6), p.e13725-n/a

2022

Volltextzugriff (PDF)

Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8‐year follow‐up data of 281 patients from the international RIT‐registry

British journal of haematology, 2019-03, Vol.184 (6), p.949-956

2019

Volltextzugriff (PDF)

Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study

Oncology research and treatment, 2022-01, Vol.45 (4), p.178-185

2022

Volltextzugriff (PDF)

Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down‐regulation of Mcl‐1 in mantle cell lymphoma

International journal of cancer, 2013-10, Vol.133 (8), p.1813-1824

2013

Volltextzugriff (PDF)

Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry

Annals of hematology, 2020-05, Vol.99 (5), p.1073-1079

2020

Volltextzugriff (PDF)

Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53

Cell death & disease, 2018-03, Vol.9 (3), p.384-14, Article 384

2018

Volltextzugriff (PDF)

Raising Immunization Rates Among Cancer Patients

Deutsches Ärzteblatt international, 2022-07, Vol.119 (26), p.466-467

2022

Volltextzugriff (PDF)

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

Annals of hematology, 2020-12, Vol.99 (12), p.2821-2829

2020

Volltextzugriff (PDF)

Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study

Transfusion medicine and hemotherapy, 2023-10, Vol.50 (5), p.403-416

2023

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(171)
Japanisch
(20)
Deutsch
(20)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(93)
Humans
(56)
Male
(30)
Female
(26)
Physical Sciences
(23)
Oncology
(21)
Aged
(20)
Middle Aged
(20)
Technology
(20)
Biological And Medical Sciences
(18)
Animals
(16)
Medical Sciences
(16)
Hematology
(15)
Adult
(13)
Medicin Och Hälsovetenskap
(11)
Science & Technology - Other Topics
(11)
Chemistry
(10)
Engineering
(10)
Lymphoma
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia

Vapor-Phase (p, ρ, T, x) Behavior of the (Hydrogen + Argon) System

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma

Speeds of Sound in n-Hexane and n-Heptane at Temperatures from (233.33 to 353.21) K and Pressures up to 20 MPa

Measurement and Correlation of the (p, ρ, T) Behavior of Liquid Methanol at Temperatures from 283.15 to 423.15 K and Pressures up to 90 MPa

Speeds of Sound in Methanol at Temperatures from 233.33 to 353.21 K at Pressures up to 20 MPa

Measurement of the (p, ρ, T) Behavior of Liquid MEA and DEA at Temperatures from (293.15 to 423.15) K and Pressures up to 90 MPa

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial

Speeds of Sound in n‑Pentane at Temperatures from 233.50 to 473.15 K at Pressures up to 390 MPa

The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network

International validation of the EORTC QLQ‐CLL17 questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia

International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20)

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

Controlled non‐randomised before–after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients—The Easy Vaccination in Oncology (EVO) strategy

Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8‐year follow‐up data of 281 patients from the international RIT‐registry

Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study

Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down‐regulation of Mcl‐1 in mantle cell lymphoma

Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry

Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53

Raising Immunization Rates Among Cancer Patients

A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study

International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27

Suchergebnisse filtern